Gowler stepping in as interim CEO of Invivyd

Invivyd Inc. (NASDAQ:IVVD) announced Jeremy Gowler, the company’s COO and chief commercial officer (CCO), has taken on the additional role of interim CEO following Thursday’s departure of Dave Hering, who also resigned from the board. Invivyd, formerly known as Adagio Therapeutics Inc., is developing antibody therapies for viral infections.

Neurodegenerative disease company FundaMental Pharma GmbH named Dirk Beher as CEO and board member, succeeding founding CEO Thomas Schulze. Beher was CEO of Asceneuron S.A., which he co-founded. ...